APPLICATION
ANDA206126
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-24
LATEST ACTION
2023-08-02
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ETOMIDATEPrescription
ETOMIDATE 2MG/ML · INJECTABLE · INJECTION
Approval history
2023-08-02Labeling · Supplement 4 · standardAP
2018-03-08Labeling · Supplement 1 · standardAP
2017-02-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.